¤@¡B¥¢¯v¥i¥H¥Î¨¦ºû¥Í¯ÀªvÀø¾¨ºÞ¨ã¦³¶Ê¯v§@¥ÎªºÃĪ«ºØÃþÁc¦h¡A¦ý¨ä¤¤¤j¦h¼ÆÃĪ«ªº¥Dn¥Î³~¨Ã¤£¬OªvÀø¥¢¯v¡C ¥Ø«eÁ{§ÉªvÀø¥¢¯vªºÃĪ«¥Dn¥]¬Af¤G´á¨ôÃþ¨üÅé¿E°Ê¾¯¡]benzodiazepinereceptoragonists¡ABZRAs¡^¡B¿Æ¶Â¯À¨ü
§Ú§Ì«Ü²r
§Ú§Ì«Ü¤[
ºë®ð¯«º¿¥d¯»
§Ú§Ì«Ü¤[
§Ú§Ì«Ü¤[©µ®É¼QÃú
§Ú§Ì«Ü¤[¨Ï¥Î¤èªk
§Ú§Ì«Ü²r¤ß±o¤À¨É
§Ú§Ì«Ü²r©xºô
Åé¿E°Ê¾¯©M¨ã¦³¶Ê¯v®ÄªGªº§Ü§íÆ{ÃĪ«¡C §Ü²ÕÓiÃĪ«¡]¦pf®ü©Ô©ú¡^¡B¿Æ¶Â¯À¥H¤Îõé¯ó´£¨úª«ÁöµM¨ã¦³¶Ê¯v§@¥Î¡A¦ý¬O²{¦³ªºÁ{§É¬ã¨sÃÒ¾Ú¦³¡A¤£©y§@¬°¥¢¯v±`³W¥ÎÃÄ¡C
°sºë¡]¤A¾J¡^¤£¯à¥Î©óªvÀø¥¢¯v¡C ¤@¯ëªºªvÀø±ÀÂË¡G¦ã¥q¦õ¤Ç§J¶©¡]eszopiclone¡^¡BÐü?©Z¡BÐü?©Z±±ÄÀ¾¯¡]zolpidem-CR¡^¡B¦õ¤Ç§J¶©¡]zopiclone¡^¡B¦ý¬OªvÀø¥¢¯vªºÃĪ«½ÆÂø¦Ó¥BÁc¦h¡A¥]¬A¡G¦ã¥qÐü¨Ú¡]estazolam¡^¡A¬t¦èÌñ¡]flurazepam¡^¡B¸Ø¦èÌñ¡]
§Ú§Ì«Ü²r®ÄªG
§Ú§Ì«Ü²r¥Îªk
§Ú§Ì«Ü²rª½À穱
§Ú§Ì«Ü¤[¹ê´ú
§Ú§Ì«Ü¤[¼v¤ù
§Ú§Ì«Ü¤[µû»ù
ºë®ð¯«º¿¥d¯»
ºë®ð¯«º¿¥d¯»®ÄªG
ºë®ð¯«º¿¥d¯»µû½×
quazepam¡^¡B*¡]temazepam¡^¡B*¡]triazolam¡^¡Bªü´¶Ðü¨Ú¡] alprazolam¡^¡B´â´á¨ô¡]chlordiazepoxide¡^¡B¦a¦è¦ñ¡]diazepam¡^¡BÅÚ©Ô¦è¦ñ¡]lorazepam¡^¡B«}èýÐü¨Ú¡]midazolam¡^¡AÐü?©Z¡BÐü?©Z±±ÄÀ¾¯¡]zolpidem-CR¡^¡B¦õ¤Ç§J¶©¡]zopiclone¡^¡B¥k¦õ¤Ç§J¶©¡]eszopiclone¡^©M*¡]zaleplon¡^¹p¬üº¸³q¡]ramelteon¡^¡B ¯S´µ¬üº¸³q¡]III.´ÁÁ{§É¤¤¡Atasimelteon¡^¡Bªü¤à¬ü©Ô¥Å¡]agomelatin¡^¡B¤TÀôÃþ§Ü§íÆ{ÃĪ«¡B¿ï¾Ü©Ê5-¦âÓi¦AÄá¨ú§í»s¾¯¡]SSRIs¡^¡B5-ßm¦âÓi©M¥h¥ÒµÇ¤W¸¢¯À¦AÄá¨ú§í¨î¡]SNRIs¡^¡B¤p¾¯¶q¦Ì´á¥¡B¤p¾¯¶q¦±ÐüଡC ©Ò¥H«Øij¦bªvÀø¥¢¯v¥ÎÃÄ¥²¶·¨ì±M¬ìÂå®v³B´N¶E¡A®Ú¾ÚÂå®v¶}¥Xªº³B¤èªAÃÄ¡C
¤G¡B¥¢¯v¬O¦]¬°¤°»òì¦]¤Þ±o
§Ú§Ì«Ü²r¦¨¤À
§Ú§Ì«Ü²rqÁÊ
§Ú§Ì«Ü²r¦Yªk
§Ú§Ì«Ü¤[¹ê´ú
§Ú§Ì«Ü¤[°Æ§@¥Î
§Ú§Ì«Ü¤[©xºô
ºë®ð¯«º¿¥d¯»¤ß±o
ºë®ð¯«º¿¥d¯»¦Yªk
ºë®ð¯«º¿¥d¯»¦¨¤À
¥¢¯v«ö¯f¦]¥i¹º¤À¬°ìµo©Ê©MÄ~µo©Ê¨âÃþ¡C
1.ìµo©Ê¥¢¯v
³q±`¯Ê¤Ö©ú½T¯f¦]¡A©Î¦b±Æ°£¥i¯à¤Þ°_¥¢¯vªº¯f¦]
§Ú§Ì«Ü²r«ç»ò¦Y
§Ú§Ì«Ü²rµû»ù
§Ú§Ì«Ü²r¯u°°
¤pôô¦ã²z§Ú§Ì«Ü¤[
§Ú§Ì«Ü¤[¯u°°
ºë®ð¯«º¿¥d¯»þ¸Ì¶R
ºë®ð¯«º¿¥d¯»°Æ§@¥Î
«á¤´¿ò¯d¥¢¯vÄpª¬¡A¥Dn¥]¬A¤ß²z¥Í²z©Ê¥¢¯v¡B¯Sµo©Ê¥¢¯v©M¥DÆ[©Ê¥¢¯v3ºØÃþ«¬¡C ìµo©Ê¥¢¯vªº¶EÂ_¯Ê¥F¯S²§©Ê«ü¼Ð¡A¥Dn¬O¤@ºØ±Æ°£©Ê¶EÂ_¡C ·í¥i¯à¤Þ°_¥¢¯vªº¯f¦]³Q±Æ°£©Îªv¡¥H«á¡A¤´¿ò¯d¥¢¯vÄpª¬®É§Y¥i¦Ò¼{¬°ìµo©Ê¥¢¯v¡C ¤ß²z¥Í²z©Ê¥¢¯v¦bÁ{§É¤Wµo²{¨ä¯f¦]³£¥i¥H·¹·½¬°¬Y¤@өΪø´Á¨Æ¥ó¹ï±wªÌ¤j¸£Ãä½t¨t²Î¥\¯àéw©Êªº¼vÅT¡AÃä½t¨t²Î¥\¯àªºÃ©w©Ê¥¢¿Å³Ì²×¾ÉP¤F¤j¸£ºÎ¯v¥\¯àªº¯¿¶Ã¡A¥¢¯vµo¥Í¡C
2.Ä~µo©Ê¥¢¯v
§Ú§Ì«Ü²r¨¾°°¼Ð
§Ú§Ì«Ü²r¹ê´ú
§Ú§Ì«Ü²r°Æ§@¥Î
§Ú§Ì«Ü¤[¤ß±o¤À¨É
ºë®ð¯«º¿¥d¤ß±o¤À¨É
¤pôô¦ã²z§Ú§Ì«Ü²r
¥]¬A¥Ñ©óÂßÅé¯e¯f¡Bºë¯«»Ùê¡BÃĪ«Àݥε¥¤Þ°_ªº¥¢¯v¡A¥H¤Î»PºÎ¯v©I§l¯¿¶Ã¡BºÎ¯v¹B°Ê»Ùêµ¥¬ÛÃöªº¥¢¯v¡C ¥¢¯v±`»P¨ä¥L¯e¯f¦P®Éµo¥Í¡A¦³®É«ÜÃø½T©w³o¨Ç¯e¯f»P¥¢¯v¤§¶¡ªº¦]ªGÃö«Y¡A¬Gªñ¦~¨Ó´£¥X¦@¯f©Ê¥¢¯v¡]comorbidinsomnia¡^ªº·§©À¡A¥Î¥H´yz¨º¨Ç¦P®É¦ñÀH¨ä¥L¯e¯fªº¥¢¯v¡C
¤T¡B¥¢¯vªº?§Éªí?¬O¤°¤\